Crossmark

Evidence of a bi-directional relationship between heart failure and diabetes: a strategy for the detection of glucose abnormalities and diabetes prevention in patients with heart failure

Crossref DOI link: https://doi.org/10.1186/s12933-024-02436-3

Published Online: 2024-09-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Valensi, Paul
License Information

Text and Data Mining valid from 2024-09-28

Version of Record valid from 2024-09-28
More Information

Article History

Received: 1 July 2024

Accepted: 10 September 2024

First Online: 28 September 2024

Declarations

:

: Not applicable.

: Not applicable.

: Paul Valensi discloses the following potential conflicts of interest: lectures for Abbott, AstraZeneca, Bayer, Clinica Medica, Eli Lilly, Hikma Pharmaceuticals, Merck Sharp & Dohme, Novo Nordisk, Novartis, Philadelphia, Pfizer, Sanofi, Servier, Stendo; research grants from Abbott, Bristol-Myers Squibb–AstraZeneca, Novo Nordisk; participation in expert committees for AstraZeneca, Boehringer Ingelheim, CEMKA, Novo Nordisk, Daiichi Sankyo, Sanofi, Servier.

Document is current

Any future updates will be listed below